Demo Sign up Log In

R&D Expenses

$2.81B

Quarterly · Period ending: Jun 28, 2026 · USD

PFE R&D Expenses

Latest reported$2.81Bperiod endingJun 28, 2026

Latest reported$2.81Bperiod endingJun 28, 2026

PFE Quarterly R&D Expenses ($0.00 → $2.81B)

Quarterly R&D Expenses

High-resolution chart · PNG

PFE r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer R&D Expenses — Quarterly (USD)
Period ending	R&D Expenses (USD)
Jul 1, 2001	1,116,000,000
Apr 1, 2001	1,028,000,000
Dec 31, 2000	1,263,000,000
Oct 1, 2000	1,025,000,000
Jul 2, 2000	1,086,000,000
Apr 2, 2000	712,000,000
Dec 31, 1999	760,000,000
Oct 3, 1999	694,000,000
Jul 4, 1999	667,000,000
Apr 4, 1999	655,000,000
Dec 31, 1998	698,000,000
Sep 27, 1998	550,000,000
Jun 28, 1998	574,000,000
Mar 29, 1998	505,000,000
Dec 31, 1997	577,000,000
Sep 28, 1997	477,000,000
Jun 29, 1997	461,000,000
Mar 30, 1997	545,000,000
Dec 31, 1996	0
Sep 29, 1996	551,000,000
Jun 30, 1996	0
Mar 31, 1996	0
Dec 31, 1995	0
Oct 1, 1995	481,000,000
Jul 2, 1995	474,000,000
Apr 2, 1995	427,000,000
Dec 31, 1994	0
Oct 2, 1994	417,000,000
Jul 3, 1994	357,000,000
Apr 3, 1994	353,000,000
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0
Dec 31, 1989	0
Sep 30, 1989	0
Jun 30, 1989	0
Mar 31, 1989	0
Dec 31, 1988	0
Sep 30, 1988	0
Jun 30, 1988	0
Mar 31, 1988	0
Dec 31, 1987	0
Sep 30, 1987	0
Jun 30, 1987	0
Mar 31, 1987	0
Dec 31, 1986	0
Sep 30, 1986	0
Jun 30, 1986	0
Mar 31, 1986	0
Dec 31, 1985	0
Sep 30, 1985	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.